Literature DB >> 8730922

Nutritional condition affects the disposition kinetics of albendazole in cattle.

S F Sánchez1, L I Alvarez, C E Lanusse.   

Abstract

1. The influence of nutritional status on the plasma and abomasal fluid disposition kinetics of albendazole (ABZ) and its metabolites, albendazole sulphoxide (ABZSO) and albendazole sulphone (ABZSO2), has been investigated in the calf. 2. Free fatty acid (FFA) and beta-hydroxybutyrate (beta-OHB) serum concentrations were significantly higher in the feed-restricted (poor nutritional status) compared with control calf (optimal nutritional status). 3. ABZ parent drug was not detected in plasma at any time post-treatment and ABZSO and ABZSO2 were the metabolites detected in plasma. Both metabolites were rapidly depleted from the bloodstream. ABZ and its metabolites were recovered in abomasal fluid from 0.25 up to either 48 (ABZ) or 120h (ABZSO and ABZSO2) post-treatment. 4. The plasma disposition kinetics of both ABZ metabolites was significantly changed in the feed-restricted compared with control calf. ABZSO and ABZSO2 plasma area under the curves (AUCs) were significantly higher in the restricted animal. These enhanced AUCs correlated with significantly longer plasma half-lives (T1/2el) and mean residence times (MRTs) for these metabolites. 5. The delayed elimination of ABZ metabolites from the bloodstream correlated with the higher concentration of these molecules recovered in the abomasal fluid of the calves subjected to a dietary restriction. 6. The changes observed on disposition kinetics may reflect an impairment on the hepatic metabolism and clearance of ABZ as a consequence of FFA mobilization from adipose tissue and overproduction of ketone bodies in the liver.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730922     DOI: 10.3109/00498259609046710

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  The effect of feed quality on the kinetic disposition of orally administered triclabendazole in sheep.

Authors:  M Oukessou; Z Souhaili
Journal:  Vet Res Commun       Date:  1998-06       Impact factor: 2.459

2.  Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.

Authors:  A Goudah
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

3.  Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic.

Authors:  Jozef Vercruysse; Jerzy M Behnke; Marco Albonico; Shaali Makame Ame; Cécile Angebault; Jeffrey M Bethony; Dirk Engels; Bertrand Guillard; Thi Viet Hoa Nguyen; Gagandeep Kang; Deepthi Kattula; Andrew C Kotze; James S McCarthy; Zeleke Mekonnen; Antonio Montresor; Maria Victoria Periago; Laurentine Sumo; Louis-Albert Tchuem Tchuenté; Thi Cam Thach Dang; Ahmed Zeynudin; Bruno Levecke
Journal:  PLoS Negl Trop Dis       Date:  2011-03-29

4.  Improvement of Albendazole Bioavailability with Menbutone Administration in Sheep.

Authors:  Raquel Diez; M Jose Diez; Juan J Garcia; Jose M Rodríguez; Cristina Lopez; Nelida Fernandez; Matilde Sierra; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2022-02-14       Impact factor: 2.752

Review 5.  Confounding factors affecting faecal egg count reduction as a measure of anthelmintic efficacy.

Authors:  Eric R Morgan; Carlos Lanusse; Laura Rinaldi; Johannes Charlier; Jozef Vercruysse
Journal:  Parasite       Date:  2022-04-07       Impact factor: 3.000

6.  Comparative plasma exposure of albendazole after administration of rapidly disintegrating tablets in dogs.

Authors:  Silvina G Castro; Alicia Dib; Gonzalo Suarez; Daniel Allemandi; Carlos Lanusse; Sergio Sanchez Bruni; Santiago D Palma
Journal:  Biomed Res Int       Date:  2013-08-25       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.